Victrex plc  

(Public, LON:VCT)   Watch this stock  
Find more results for VCT
1,943.00
+42.00 (2.21%)
Apr 17 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 1,904.00 - 1,955.00
52 week 1,459.00 - 2,042.00
Open 1,907.00
Vol / Avg. 76,285.00/101,872.00
Mkt cap 1.65B*
P/E 22.58
Div/yield 32.65/2.21*
EPS 0.86*
Shares 85.15M
Beta     -
Inst. own     -
*GBP
Feb 4, 2014
Victrex PLC Annual General Meeting
  

Key stats and ratios

Q3 (Sep '13) 2013
Net profit margin 32.73% 32.85%
Operating margin 42.08% 42.36%
EBITD margin - 46.78%
Return on average assets 21.44% 21.03%
Return on average equity 25.66% 24.93%
Employees 644 -
CDP Score - 53 E

Address

Victrex Technology Centre Hillhouse International Thornton Cleveleys
THORNTON CLEVELEYS, ENG FY5 4QD
United Kingdom - Map
+44-1253-897700 (Phone)
+44-1253-897701 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Victrex plc is a holding company. The Company is a manufacturer of high-performance polyaryletherketones, including VICTREX PEEK polymer. Its business is organized as two business units: Victrex Polymer Solutions (VPS) and Invibio Biomaterial Solutions (Invibio). VPS provides a range of products, together with technical and marketing support to its customers and end users to help them deliver new, cost effective solutions in its markets of industrial, transport and electronics. Invibio provides versatile PEEK-based polymers to address the needs of the long-term implantable medical device market. Its materials are used across a number of applications, including spinal fusion and motion preservation, arthroscopy, joint replacement, trauma, cardio-neuro and cranio-maxillo facial implants. The Company�s subsidiaries include Victrex Manufacturing Limited, invibio Limited, Victrex Japan, Inc. Victrex USA, Inc. and Invibio USA, Inc.

Officers and directors

David R. Hummel Chief Executive, Executive Director
Louisa Burdett Group Finance Director, Director
Suzana Koncarevic General Counsel, Company Secretary
Martin Court Ph.D. Managing Director - Invibio
Tim J. Cooper Executive Director
Carolyn MacNab Group Human Resources Director
John Devine Ph.D. Emerging Business Director
Kenny Gilmour Operations Director
Anita M. Frew Non-Executive Independent Chairman of the Board
Age: 55
Patrick J. M. De Smedt Non-Executive Independent Director